| Synonyms: | Cyanomorpholinoadriamycin;Mra-CN;NSC 357704;BRN 6050053;MRA-CN isomer a, a:b = 93:7;3'-(3-Cyano-4-morpholinyl)-3'-deamino-adriamycin;3'-Deamino-3'-(3-cyano-4-morpholinyl)doxorubicin;cyanomorpholino doxorubicin;AC1L2O8V;Neuro_000195;CCRIS 5080;YIMDLWDNDGKDTJ-UHFFFAOYSA-N;(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-(3-cyanomorpholin-4-yl)-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside;5,12-Naphthacenedione, 10-((3-(3-cyano-4-morpholinyl)-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-;5,12-Naphthacenedione, 7,8,9,10-tetrahydro-10-((3-(3-cyanomorpholino)-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-8-(hydroxyacetyl)-1-methoxy-6,8,11-trihydroxy-, (8s-cis)-;88254-07-3;C32H34N2O12;MRA-CN isomer b, a:b=17:83;NSC639650;NSC639651;NSC-639650;NSC-639651;LS-94088;NCI60_013156;A 489;A-489;3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin;D335F8F4BD369D6DAED5217130193378;3'-Deamino-3'-(3-cyano-4-morpholinyl) doxorubicin, isomer a;3'-Deamino-3'-(3-cyano-4-morpholinyl)doxorubicin, isomer b;4-[3-hydroxy-2-methyl-6-[[3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]oxan-4-yl]morpholine-3-carbonitrile;5,12-Naphthacenedione, 10-((3-(3-cyano-4-morpholinyl)-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- |
| InChI: | InChI=1S/C32H34N2O12/c1-14-27(37)18(34-6-7-44-13-15(34)11-33)8-22(45-14)46-20-10-32(42,21(36)12-35)9-17-24(20)31(41)26-25(29(17)39)28(38)16-4-3-5-19(43-2)23(16)30(26)40/h3-5,14-15,18,20,22,27,35,37,39,41-42H,6-10,12-13H2,1-2H3 |
